Covance Not Cooling...
Health Care: Drugs
Alexion Pharmaceuticals Inc. (ALXN: NASDAQ)
$100.03 -2.87 | -2.79%
05/20/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 102.90 |
| 52 Week High | 119.54 |
| 52 Week Low | 81.82 |
| Avg. Daily Vol. (Mil) | 1.77 |
| Beta (3 year) | 0.54 |
| Share Related Items | |
| Mkt Cap (Mil) | 20,080.59 |
| Shares Out (Mil) | 195.15 |
| Float (Mil) | 171.52 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 4.60 |
| Current Ratio | 5.20 |
| LT Debt/ Equity | 0.05 |
| Total Debt / Equity | 0.07 |
| Valuation Ratios | |
| Price Earnings | 71.00 |
| Price/Sales | 16.35 |
| Price/Book | 9.61 |
| Price/Cash Flow | 71.80 |
| Per Share Data | |
| Earnings | 1.45 |
| Sales | 6.29 |
| Book Value | 10.71 |
| Cash Flow | 1.43 |
| Business Summary | |
|---|---|
| Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. | |
| General Information | |
| 352 Knotter Drive
Cheshire, CT 06410 |
|
| www.alexionpharm.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1373 | |
| CEO: Dr. Leonard Bell,M.D. | |
| Short Interest | |
| Current Month (Mil) | 4.34 |
| Previous Month (Mil) | 4.58 |
| Short Interest Ratio (Days) | 2.30 |
| Management Effectiveness | |
| Return on Equity | 12.20 |
| Return on Assets | 9.50 |
| Return on Investments | 11.70 |
| Profitability | |
| Gross Margin | 91.10 |
| EBIT Margin | 36.90 |
| Profit Margin | 20.80 |
Portfolios with ALXN
- Portfolio NameUser Type
- User5 S&P 500 stocks poised for...
- ProNavellier & Associates
- UserGFNN Stockdiagnostics 27
- ContributorRocket Stocks for the Week ...
- UserRenzo's portfolio
- UserBender
- UserGFNN Stockdiagnostics 18
- Contributor10 Stocks of Top-Performing...
- UserMoney Making Machine
- UserGFNN Stockdiagnostics 17
Latest ALXN Headlines from TheStreet
- Alexion Pharmaceuticals Inc. Stock Buy Recommendation Reiterated (ALXN) 04.19.13 | 10:04 am
- Worth Repeating: Vertex Is the Next Gilead Sciences 04.19.13 | 08:04 am
- 5 Stocks Pushing The Drugs Industry Downward 04.15.13 | 01:04 pm
- Top Insider Trades: DGIT GDP ALXN SPB 04.15.13 | 08:04 am
- Alexion Pharmaceuticals Becomes #42 Most Shorted Nasdaq 100 Component, Replacing KLA-Tencor 04.10.13 | 04:04 pm
- Market Takes Aim at Historic Highs Once Again
04.10.13 | 09:04 am - Alexion Pharmaceuticals Inc. (ALXN): Today's Favorite Health Care Gainer 04.04.13 | 05:04 pm
- Mad Money Uncovered: Biomarin and Alexion Orphan Drug Stalwarts 04.02.13 | 11:04 am
- Cramer's Top Stock Picks: HES ALXN BMRN NFLX ENB AWK 04.02.13 | 06:04 am
- Cramer's 'Mad Money' Recap: Checking My List 04.01.13 | 07:04 pm
Press Releases for ALXN
- Alexion Joins The International Federation Of Kidney Foundations In Celebrating World Kidney Day 2013 - Business Wire 03.14.13 | 06:03 am
- Alexion To Present At The Barclays Global Healthcare Conference - Business Wire 03.05.13 | 10:03 am
- Alexion Joins Eurordis, NORD And Patient Organizations Worldwide In Celebrating Rare Disease Day 2013 - Business Wire 02.28.13 | 06:02 am
- Alexion To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.25.13 | 10:02 am
- Alexion Reports Fourth Quarter And Full Year 2012 Results - Business Wire 02.14.13 | 06:02 am
- Alexion Recommends Rejection Of Mini-Tender Offer By TRC Capital Corporation - Business Wire 02.07.13 | 06:02 am
- Alexion Pharmaceuticals To Report Fourth Quarter And Full Year 2012 Results On Thursday, February 14, 2013 - Business Wire 01.31.13 | 10:01 am
- Alexion To Present At The JP Morgan 31st Annual Healthcare Conference - Business Wire 01.02.13 | 10:01 am
- New Data Highlighting Long-Term Efficacy And Safety Outcomes Of PNH Patients Treated With Soliris® Reported At ASH Annual Meeting - Business Wire 12.10.12 | 10:12 am
- Alexion To Present At The 24th Annual Piper Jaffray Healthcare Conference - Business Wire 11.21.12 | 10:11 am
Partner Headlines for ALXN
- Short Interest in Vertex Rises, in Celgene Falls - Benzinga 05.11.13 | 10:05 am
- Indexes End Near Highs Ahead Of Earnings from Apple, Cree - Investor's Business Daily 04.23.13 | 04:04 pm
- Alexion Pharmaceuticals Earnings Preview: Can This Streak Continue? - Wall St. Cheat Sheet 04.23.13 | 06:04 am
- Stocks Maintain Early Lead; Drugmakers Alexion, Regeneron Climb - Investor's Business Daily 04.02.13 | 12:04 pm
- Market Close Report: NASDAQ Composite index closes at 3,239.17 down -28.35 points - NASDAQ 04.01.13 | 08:04 pm
- Regeneron Pharmaceuticals Inc (REGN): Today's Most Compelling Buy - NASDAQ 03.14.13 | 04:03 pm
- Market Close Report: NASDAQ Composite index closes at 3,182.03 up 12.29 points - NASDAQ 03.04.13 | 09:03 pm
- Trouble At A Stock's Breakout Could Be Sell Signal - Investor's Business Daily 03.04.13 | 05:03 pm
- Following The Leaders Is Way To Reap Windfall Profits - Investor's Business Daily 02.22.13 | 04:02 pm
- Market Close Report: NASDAQ Composite index closes at 3,131.49 down -32.92 points - NASDAQ 02.21.13 | 09:02 pm
